Patients at Low Risk for Chronic Kidney Disease Progression Don't Benefit From ARBs

---

Citation:

Mann JF, Schmieder RE, Dyal L, et al. Effect of telmisartan on renal outcomes: a randomized trial. Ann Intern Med. 2009;151:1-10, W1-2. Epub 2009 May 18.